Abramson Cancer Center at Penn Medicine: Carcinoma trials

The registry lists 18 Carcinoma studies with Abramson Cancer Center at Penn Medicine as lead sponsor. 0 are open to participants now and 6 have results posted.

Early Phase 1 2Phase 1 7Phase 2 6No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Abemaciclib and Nivolumab for Subjects With Hepatocellular CarcinomaTerminatedNCT03781960Phase 2Results posted
• Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckCompletedNCT02207439Phase 2Results posted
• Phase 1-2 Trial HCQ Plus TACE in Unresectable HCCTerminatedNCT02013778Phase 1/2Results posted
• A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the PancreasCompletedNCT01985958Not applicableResults posted
• Brivanib Metastatic Renal Cell CarcinomaTerminatedNCT01253668Phase 2Results posted
• Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and NeckCompletedNCT01044433Phase 2Results posted
• Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)WithdrawnNCT06337162Phase 1
• Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected PrimaryTerminatedNCT04429321Phase 1
• Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02906397Phase 1
• HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck CancerCompletedNCT01984359Not applicable
• Intraoperative Imaging of Breast Cancer With Indocyanine GreenCompletedNCT01796041Early Phase 1
• CRLX101 Plus Bevacizumab in Advanced RCCCompletedNCT01625936Phase 1
• Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E HistologyCompletedNCT01540695
• Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell CarcinomaCompletedNCT01510119Phase 1/2
• Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)CompletedNCT01221506Early Phase 1
• Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerCompletedNCT01042041Phase 1
• Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT01026337
• Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxCompletedNCT01020097Not applicable